About 25 per cent do not respond well to AED therapy but some may be offered other treatments such as surgery. New drugs under investigation Remacemide - under investigation. If prescibed with Tegretol, the dose of Tegretol needs to be monitored very carefully and usually reduced. This can also occur with AEDs. First Line Drugs First line describes the principal drugs of first choice.
Dose needs to be individually adjusted.
Ineffective against absences. Serum level monitoring essential. Blurred vision, double vision, drowsiness, unsteadiness and slurred speech may occur if the dose is too high. Coarsening of facial features, overgrowth of gums and acne may be a problem with prolonged use, as well as an increase in body hair. Ineffective against absences.